Johnson & Johnson's Rybrevant gets conditional approval in Canada for lung cancer subtype
April 04 2022 - 7:23AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024